Trial · NCT07104526
Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH)
NCT07104526, Not applicable, Completed, Wuhan Integrated Traditional Chinese and Western Medicine Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH). Trials, record NCT07104526. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07104526
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH)
- NCT number
- NCT07104526
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 260 participants, actual
- Lead sponsor
- Wuhan Integrated Traditional Chinese and Western Medicine Hospital
- Conditions
- Infantile Hemangioma (IH)
- Interventions
- Propranolol + Bleomycin, Propranolol
- First posted
- 2025-08-05
- Last updated
- 2025-08-05
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Clinical Therapeutic Effect | 6 Months | Categorized as Complete Regression (\>95% volume reduction), Marked Effectiveness (≥75% to 95% volume reduction), Effective (30% to \<75% reduction), or Ineffective (\<30% reduction). The primary measure is the rate of participants achieving Complete Regression or Marked Effectiveness. |
| Secondary | Early Tumor Surface Atrophy | 24 hours after the first treatment | Assessed by comparing photographs and graded as Obvious Atrophy, Mild Atrophy, or No Obvious Change. |
| Secondary | Change in Hemangioma Color Score | Baseline, 6 Months | Rated on a 4-point subjective scale (0-3) based on standardized digital photographs, where a lower score indicates color closer to normal skin. The change from baseline is assessed. |
| Secondary | Change in Tumor Volume | Baseline, 6 Months | Measured in cubic centimeters (cm³) using high-frequency color Doppler ultrasound (Volume = length × width × height × 0.52). The change from baseline is assessed. |
| Secondary | Vancouver Scar Scale (VSS) Score | 6 Months | Assessed at the former hemangioma site. The VSS evaluates pigmentation, vascularity, pliability, and height, with a total score from 0 (normal skin) to 13 (worst scar). Lower scores indicate better outcomes. |
| Secondary | Incidence of Adverse Events | Through study completion (6 months) | Number and type of local and systemic adverse events reported by guardians or observed clinically (e.g., injection site reactions, bradycardia, hypoglycemia, sleep disturbances). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07104526
GET https://conductscience.org/api/trials/v1/NCT07104526/registered